0001104659-24-022486.txt : 20240213 0001104659-24-022486.hdr.sgml : 20240213 20240213190216 ACCESSION NUMBER: 0001104659-24-022486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240211 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlessinger Sam CENTRAL INDEX KEY: 0001914168 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 24630974 MAIL ADDRESS: STREET 1: 100 SOUTH SAUNDERS ROAD, SUITE 300 CITY: LAKE FORREST STATE: IL ZIP: 60045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 tm245969-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-11 0 0001808665 Assertio Holdings, Inc. ASRT 0001914168 Schlessinger Sam ASSERTIO HOLDINGS, INC. 100 SOUTH SANDERS ROAD, SUITE 300 LAKE FORREST IL 60045 0 1 0 0 SVP, General Counsel 0 Common Stock 2024-02-11 4 M 0 18939 0 A 98785 D Common Stock 2024-02-11 4 F 0 6552 0.80 D 92233 D Restricted Stock Units 0.0 2024-02-11 4 M 0 18939 0 D 2024-02-11 Common Stock 18939 0 D Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units. Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. One-third of these restricted stock units are scheduled to vest on each of February 11, 2022, 2023, and 2024, assuming continued employment through the applicable vesting date. The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. /s/ Sam Schlessinger 2024-02-13